{"organizations": [], "uuid": "16c0a52721c073c58e6cc47fa5b36157a55a1a84", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/04/24/105156380-3ED1-RND-CharlesLi-042418.600x400.jpg", "site_section": "http://www.cnbc.com/id/100004038/device/rss/rss.html", "section_title": "Latest Video", "url": "https://www.cnbc.com/video/2018/04/24/why-the-hkex-is-wooing-biotech-firms-ceo.html", "country": "US", "domain_rank": 767, "title": "Why the HKEX is wooing biotech firms: CEO", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-25T01:25:00.000+03:00", "replies_count": 0, "uuid": "16c0a52721c073c58e6cc47fa5b36157a55a1a84"}, "author": "", "url": "https://www.cnbc.com/video/2018/04/24/why-the-hkex-is-wooing-biotech-firms-ceo.html", "ord_in_thread": 0, "title": "Why the HKEX is wooing biotech firms: CEO", "locations": [], "entities": {"persons": [{"name": "charles li", "sentiment": "negative"}], "locations": [{"name": "hong kong", "sentiment": "none"}], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Why the HKEX is wooing biotech firms: CEO 4 Hours Ago Charles Li of Hong Kong Exchanges and Clearing says access to capital is critical for highly-regulated companies developing drugs.", "external_links": [], "published": "2018-04-25T01:25:00.000+03:00", "crawled": "2018-04-25T06:08:21.000+03:00", "highlightTitle": ""}